The self-catalytic RNA motifs of the hepatitis delta virus;Le mofif autocatalytique d'ARN du virus delta de l'hepatite humaine

Medecine/Sciences

Volumn 13, Issue 5, 1997, Pages 662-669

  Mercure, Stéphane ^b   Lafontaine, Daniel ^b   Roy, Guylaine ^b   Perreault, Jean Pierre ^a,b  

^a Conseil Rechercha Medicales Canada ^*  (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOZYME; VIRUS RNA;

ARTICLE; CATALYSIS; HEPATITIS DELTA VIRUS; NONHUMAN; RNA CLEAVAGE; RNA STRUCTURE; VIRUS REPLICATION;

DELTA VIRUS; HEPATITIS DELTA VIRUS; VIROIDS;

EID: 0030983392     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/434     Document Type: Article

References (32)

1. Lazinski DW, Taylor JM. Recent development in hepatitis delta virus research. Adv Virus Res 1994; 43: 187-231.
2. Poisson F, Roingeard P, Goudeau A. Le virus de l'hépatite delta: un mode de replication bien singulier. Med Sci 1995; 10: 1379-87.
3. Lai MMC. The molecular biology of hepatitis delta virus. Annu Rev Biochem 1995; 64: 259-86.
4. Branch AD, Levine BJ, Robertson HD. The brotherhood of circular RNA pathogens: viroids, circular satellites and the delta agent. Semin Virol 1990; 1: 143-52.
5. Symons RH. The small catalytic RNA. Annu Rev Biochem 1992; 61: 641-71.
6. Been MD. Cis- and trans-acting ribozymes from a human pathogen hepatitis delta virus. Trends Biochem Sci 1994; 19: 251-6.
7. Makino S, Chang MF, Shieh CK, Kamahora T, Vannier DM, Govindarajan S, Lai MMC. Molecular cloning and sequencing of a human hepatitis delta virus RNA. Nature 1987; 329: 343-6.
8. Polson AG, Bass BL, Casey JL. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 1996; 380: 454-6.
9. Lazinski DW, Taylor JM. Regulation of the hepatitis delta virus ribozymes : To cleave or not to cleave? RNA 1995; 1: 225-33.
10. Sharmeen L, Kuo MYP, Dinter-Gottlieb G, Taylor J. The antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol 1988; 62: 2674-9.
11. Lazinski DW, Taylor JM. Intracellular cleavage and ligation of hepatitis delta virus genomic RNA: regulation of ribozyme activity by cis-acting sequences and host factors. J Virol 1995; 69: 1190-200.
12. Sharmeen L, Kuo MYP, Taylor J. Self-ligating RNA sequences on the antigenome of human hepatitis delta virus. J Virol 1989; 63: 1428-30.
13. Smith JB, Gottlieb PA, Dinter-Gottlieb G. A sequence element necessary for self-cleavage of the antigenomic hepatitis delta RNA in 20M formamide. Biochemistry 1992; 31: 9629-35.
14. Branch AD, Robertson HD. Efficient trans cleavage and a common structural motif for the ribozymes of the human hepatitis delta agent. Proc Natl Acad Sci USA 1991; 88: 10163-7.
15. Tanner NK, Schaf S, Thill G, Petit-Koskas E, Crain-Denoyelle AM, Westhof E. A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses. Curr Biol 1994; 4: 488-98.
16. Been MD, Perrotta AT. Optimal self-cleavage activity of the hepatitis delta virus RNA is dependent on a homopurine base pair in the ribozyme core. RNA 1995; 1: 1061-70.
17. Suh YA, Kumar PKR, Kawakami J, Nishikawa F, Taira K, Nishikawa S. Systematic substitution of individual bases in two important single-stranded regions of the HDV ribozyme for evaluation of the role of specific bases. FEBS Lett 1993; 326: 158-62.
18. Kawakami J, Kumar PKR, Suh YA, Nishikawa F, Kawakami K, Taira K, Ohtsuka E, Nishikawa S. Identification of important bases in a single-stranded region (SSrC) of the hepatitis delta (δ) virus ribozyme. Eur J Biochem 1993; 217: 29-36.
19. Branch AD, Polaskova JA. 3-D models of the antigenomic ribozyme of the hepatitis delta agent with eight new contacts suggested by sequence analysis of 188 cDNA clones. Nucleic Acids Res 1995; 23: 4180-9.
20. Perrotta AT, Been MD. Core sequences and a cleavage site wobble pair required for HDV antigenomic ribozyme self-cleavage. Nucleic Acids Res 1996; 24: 1314-21.
21. Bravo C, Lescure F, Laugâa P, Fourrey JL, Favre A. Folding of the HDV antigenomic ribozyme pseudoknot structure deduced from long-range photocrosslinks. Nucleic Acida Res 1996; 24: 1351-9.
22. Kumar PKR, Taira K, Nishikawa S, Chemical probing studies of variants of the genomic hepatitis delta virus ribozyme by primer extension analysis. Biochemistry 1994; 33: 583-92.
23. Lee CB, Lai YC, Ping VH, Huang ZS, Lin JY, Wu HN. The importance of the helix 2 region for the cis-cleaving and trans-cleaving activities of hepatitis delta virus ribozymes. Biochemistry 1996; 35: 12303-12.
24. Altman S. RNA enzyme-directed gene therapy. Proc Natl Acad Sci USA 1993; 90: 10898-900.
25. Hélène C, Saison-Behmoaras E. La stratégie anti-sens: nouvelles approches thérapeutiques. Med Sci 1994; 10: 253-73.
26. Perreault JP, Altman S. La ribonucléase P : une véritable enzyme à ARN in vitro. Med Sci 1991; 7: 847-50.
27. Li Y, Altman S. Cleavage by RNase P of gene N mRNA reduces bacteriophage λ burst size. Nucleic Acids Res 1996; 24: 835-42.
28. Herschlag D. Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better. Proc Natl Acad Sci USA 1991; 88: 6921-5.
29. Ohkawa J, Koguma T, Kohda T, Taira K. Ribozymes: from mechanistic studies to applications in vivo. J Biochem 1995; 118: 251-8.
30. Chowrira BM, Pavco PA, McSwiggen JA. In vitro and in vivo comparison of hammerhead, hairpin, and hepatitis delta virus self-processing ribozyme cassettes. J Biol Chem 1994; 269: 25856-64.
31. Xing Z, Mahadeviah S, Whitton JL. Antiviral activity of RNA molecules containing self-releasing ribozymes targeted to Iymphocytic chroriomeningitis virus. Antisense Res Dev 1995; 5: 203-12.
32. Polo JM, Lim B, Govindarajan S, Lai MMC. Replication of hepatitis delta virus RNA in mice after intramuscular injection of plasmid DNA. J Virol 1995; 69: 5203-7.